Literature DB >> 12422156

Sex differences in QTc interval and QT dispersion: dynamics during exercise and recovery in healthy subjects.

Vijay S Chauhan1, Andrew D Krahn, Bruce D Walker, George J Klein, Allan C Skanes, Raymond Yee.   

Abstract

BACKGROUND: Sex differences have been described in resting cardiac repolarization and susceptibility to torsade de pointes in humans. This study compares the QT-interval and QT-dispersion dynamics during exercise and recovery between healthy men and women.
METHODS: Twenty healthy subjects (10 males aged 30 +/- 4 years, 10 females aged 31 +/- 11 years) underwent symptom-limited bicycle ergometry followed by a 10-minute recovery period. Digital 12-lead electrocardiograms (ECG) were recorded every 10 seconds during exercise and recovery. For each lead, the QTp interval (Q onset to T peak) was automatically measured by use of QT Guard (GE Marquette, Milwaukee, Wis). QTp dispersion was defined as the difference between the maximum and minimum QTp for each ECG. To quantify QT dynamics, we fit the QTp in lead V(3) (QTpV(3)) versus cycle length (CL) relationship to a quadratic function during exercise and recovery with nonlinear regression analysis. Similar regression analysis was performed for the QTp dispersion versus CL relationship.
RESULTS: At baseline, QTpcV(3) was longer in women than in men (338 +/- 25 vs 278 +/- 15 ms, P <.0001), but QTp dispersion was similar (35 +/- 18 vs 41 +/- 19 ms). At peak exercise, QT dispersion decreased compared with baseline in both men and women. During exercise and recovery, women had a steeper QTpV(3)-CL relationship. QTpV(3) hysteresis, a measure of the exercise and recovery QTpV(3)-CL curve separation, was greater in women than in men when measured 1 minute into recovery (33 +/- 20 vs 6 +/- 8 ms, P <.001). No sex difference in QTp-dispersion-rate adaptation was observed during exercise or recovery.
CONCLUSIONS: Healthy women exhibit greater QT-interval-rate adaptation during both exercise and recovery than men, resulting in more QT-interval hysteresis. Greater QT prolongation during decelerating heart rates in recovery may play a role in increasing proarrhythmia risk in women.

Entities:  

Mesh:

Year:  2002        PMID: 12422156     DOI: 10.1067/mhj.2002.125619

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  13 in total

1.  QT-RR hysteresis is caused by differential autonomic states during exercise and recovery.

Authors:  Daniel J Pelchovitz; Jason Ng; Alexandru B Chicos; Daniel W Bergner; Jeffrey J Goldberger
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-27       Impact factor: 4.733

2.  Dynamics and rate-dependence of the spatial angle between ventricular depolarization and repolarization wave fronts during exercise ECG.

Authors:  Tuomas Kenttä; Mari Karsikas; Antti Kiviniemi; Mikko Tulppo; Tapio Seppänen; Heikki V Huikuri
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-07       Impact factor: 1.468

3.  Lack of correlation between exercise and sibenadet-induced changes in heart rate corrected measurement of the QT interval.

Authors:  Paul Newbold; Nick Sanders; Stots B Reele
Journal:  Br J Clin Pharmacol       Date:  2006-09-12       Impact factor: 4.335

4.  Use of a novel transfer function to reduce repolarization interval hysteresis.

Authors:  Josef Halámek; Pavel Jurák; T Jared Bunch; Jolana Lipoldová; Miroslav Novák; Vlastimil Vondra; Pavel Leinveber; Martin Plachy; Tomas Kara; Marco Villa; Petr Frána; Miroslav Soucek; Virend K Somers; Samuel J Asirvatham
Journal:  J Interv Card Electrophysiol       Date:  2010-07-13       Impact factor: 1.900

Review 5.  Categorization and theoretical comparison of quantitative methods for assessing QT/RR hysteresis.

Authors:  Hugo Gravel; Daniel Curnier; Nagib Dahdah; Vincent Jacquemet
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-05-16       Impact factor: 1.468

6.  Rate-independent QT shortening during exercise in healthy subjects: terminal repolarization does not shorten with exercise.

Authors:  Prince J Kannankeril; Paul A Harris; Kris J Norris; Irfan Warsy; Phillip D Smith; Dan M Roden
Journal:  J Cardiovasc Electrophysiol       Date:  2008-07-28

7.  Participation of women and sex analyses in late-phase clinical trials of new molecular entity drugs and biologics approved by the FDA in 2007-2009.

Authors:  Rita Poon; Keshav Khanijow; Sphoorti Umarjee; Emmanuel Fadiran; Monica Yu; Lei Zhang; Ameeta Parekh
Journal:  J Womens Health (Larchmt)       Date:  2013-06-14       Impact factor: 2.681

8.  The high frequency relationship: implications for torsadogenic hERG blockers.

Authors:  P Champeroux; J Y Le Guennec; S Jude; C Laigot; A Maurin; M L Sola; J S L Fowler; S Richard; J Thireau
Journal:  Br J Pharmacol       Date:  2016-01-14       Impact factor: 8.739

9.  Methodological considerations in the design of trials for safety assessment of new drugs and chemical entities.

Authors:  Cornel Pater
Journal:  Curr Control Trials Cardiovasc Med       Date:  2005-02-03

10.  Sex Differences in Correlates of Intermediate Phenotypes and Prevalent Cardiovascular Disease in the General Population.

Authors:  Renate B Schnabel; Philipp S Wild; Jürgen H Prochaska; Francisco M Ojeda; Tanja Zeller; Nargiz Rzayeva; Ariana Ebrahim; Karl J Lackner; Manfred E Beutel; Norbert Pfeiffer; Christoph R Sinning; Sabine Oertelt-Prigione; Vera Regitz-Zagrosek; Harald Binder; Thomas Münzel; Stefan Blankenberg
Journal:  Front Cardiovasc Med       Date:  2015-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.